Ali Arbab, MD, has been awarded a grant by the National Institute of Neurological Disorders and Stroke (NINDS), demonstrating the translational ability of his new technology.
Up to 90% of patients with these brain injuries experience collateral damage to brain tissue adjacent to the site of the injury hours and sometimes even days later, worsening damage and potential recovery prospects.